Three-class classification models of logS and logP derived by using GA–CG–SVM approach

In this investigation, three-class classification models of aqueous solubility (logS) and lipophilicity (logP) have been developed by using a support vector machine (SVM) method combined with a genetic algorithm (GA) for feature selection and a conjugate gradient method (CG) for parameter optimization. A 5-fold cross-validation and an independent test set method were used to evaluate the SVM classification models. For logS, the overall prediction accuracy is 87.1% for training set and 90.0% for test set. For logP, the overall prediction accuracy is 81.0% for training set and 82.0% for test set. In general, for both logS and logP, the prediction accuracies of three-class models are slightly lower by several percent than those of two-class models. A comparison between the performance of GA–CG–SVM models and that of GA–SVM models shows that the SVM parameter optimization has a significant impact on the quality of SVM classification model. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users. Hui Zhang and Ming-Li Xiang are contributed equally.     

Docking and quantitative structure–activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase

We have performed the docking of sulfonyl hydrazides complexed with cytosolic branched-chain amino acid aminotransferase (BCATc) to study the orientations and preferred active conformations of these inhibitors. The study was conducted on a selected set of 20 compounds with variation in structure and activity. In addition, the predicted inhibitor concentration (IC₅₀) of the sulfonyl hydrazides as BCAT inhibitors were obtained by a quantitative structure–activity relationship (QSAR) method using three-dimensional (3D) vectors. We found that three-dimensional molecule representation of structures based on electron diffraction (3D-MoRSE) scheme contains the most relevant information related to the studied activity. The statistical parameters [cross-validate correlation coefficient (Q ² = 0.796) and fitted correlation coefficient (R ² = 0.899)] validated the quality of the 3D-MoRSE predictive model for 16 compounds. Additionally, this model adequately predicted four compounds that were not included in the training set.     

Theoretical study of GSK−3<Emphasis Type="Italic">α</Emphasis>: neural networks QSAR studies for the design of new inhibitors using 2D descriptors

Glycogen synthase kinase-3 (GSK-3) targets encompass proteins implicated in AD and neurological disorders. The functions of GSK-3 and its implication in various human diseases have triggered an active search for potent and selective GSK-3 inhibitors. In this sense, QSAR could play an important role in studying these GSK-3 inhibitors. For this reason, we developed QSAR models for GSK−3α, linear discriminant analysis (LDA), and artificial neural networks (ANNs) from nearly 50,000 cases with more than 700 different GSK−3α inhibitors obtained from ChEMBL database server; in total we used more than 20,000 different molecules to develop the QSAR models. The model correctly classified 237 out of 275 active compounds (86.2%) and 14,870 out of 15,970 non-active compounds (93.2%) in the training series. The overall training performance was 93.0%. Validation of the model was carried out using an external predicting series. In these series, the model classified correctly 458 out of 549 (83.4%) compounds and 29,637 out of 31,927 non-active compounds (83.4%). The overall predictability performance was 92.7%. In this study, we propose three types of non-linear ANN as alternative to already existing models, such as LDA. Linear neural network: LNN: 236:236-1-1:1 which had an overall training performance of 96% proved to be the best model. In addition, we did a study of the different fragments of the molecules of the database to see which fragments had more influence in the activity. This can help design new inhibitors of GSK−3α. This study reports the attempts to calculate, within a unified framework probabilities of GSK−3α inhibitors against different molecules found in the literature.